CG-105-12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CG-105-12, covering 2025-05-31 to 2025-05-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]